MENU

Fox Chase Cancer Center News

January 20, 2022

Fox Chase Cancer Center’s Camille Ragin Receives Grant to Take Part in International Effort to Study Black Genomes

PHILADELPHIA (January 20, 2022)—Camille Ragin, PhD, MPH, a professor in the Cancer Prevention and Control research program at Fox Chase Cancer Center, is a member of a team that was recently awarded a grant as part of an international effort to decode Black genomes and investigate what drives breast, ovarian, and prostate cancer

January 5, 2022

Fox Chase Researchers to Use NIH Grant to Develop Platform for Testing New Drug Therapies for Pancreatic Cancer

PHILADELPHIA (January 5, 2022)— Researchers at Fox Chase Cancer Center recently received a $497,000 multi-year grant from the National Cancer Institute within the National Institutes of Health to develop a way to evaluate novel drug therapies in patients with pancreatic cancer.

January 4, 2022

Fox Chase Cancer Center Welcomes Dr. Danish Ahmad

PHILADELPHIA (January 4, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Danish Ahmad, MD, as an assistant professor in the Department of Medicine for the Division of Pulmonary, Sleep and Critical Care Medicine.

December 17, 2021

Dr. Jeffrey Farma Elected to Leadership Position in the Society of University Surgeons

PHILADELPHIA (December 17, 2021)—Jeffrey M. Farma, MD, FACS, chief of the Division of General Surgery and co-director of the Melanoma and Skin Cancer Program at Fox Chase Cancer Center, has been elected a member-at-large for the Society of University Surgeons (SUS). According to the SUS, the member-at-large position is an important part of its nominating committee. 

December 15, 2021

Dr. Stephanie Greco Inducted as Fellow Into the American College of Surgeons

PHILADELPHIA (December 15, 2021)—Stephanie Greco, MD, FACS, an assistant professor in the Department of Surgical Oncology at Fox Chase Cancer Center, became a Fellow of the American College of Surgeons (FACS) during the convocation ceremony at the ACS Clinical Congress, which was held virtually October 23-27.

December 14, 2021

Fox Chase’s Y. Lynn Wang Presents Research at Hematology Meeting That Could Help Predict Effectiveness of Cancer Drug

PHILADELPHIA (December 14, 2021)—Loss of the protein-tyrosine phosphatase SHP1 may be used as a biomarker to predict efficacy of ibrutinib in certain cases of diffuse large B-cell lymphoma (DLBCL), according to the results of a study by Fox Chase Cancer Center researchers presented in a poster at the 63rd ASH Annual Meeting and Exposition.

    December 13, 2021

    Fox Chase Graduate Student Billy Truong Recognized With ASH Abstract Achievement Award

    PHILADELPHIA (December 13, 2021)—Billy Truong, a doctoral candidate at Fox Chase Cancer Center, was awarded the American Society of Hematology (ASH) Abstract Achievement Award for a poster that he presented at the 63rd ASH Annual Meeting and Exposition.

    December 2, 2021

    Two Fox Chase Cancer Center Researchers Join American Lung Association’s 2021-2022 Research Team and Receive a Total Research Investment of $200,000 to Improve Lung Health and Prevent Lung Disease

    PHILADELPHIA (December 2, 2021) – As new and pressing lung health challenges emerge due to factors such as the COVID-19 pandemic, climate change, and youth e-cigarette use, researchers continue to be at the forefront of scientific breakthroughs. In Philadelphia, two distinguished scientists from Fox Chase Cancer Center are being awarded research grants to help study how lung cancer impacts people’s lives.

    Pages

    Connect with Fox Chase